This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Competition Law & Patent Litigation

Get up to speed on the biggest pharmaceutical sector antitrust cases, new developments from the EU Commission and patents

Discuss the latest insights and case law

Take a look at some of the talks covered below:

Excessive Pricing in the Pharmaceutical Industry
Excessive Pricing in the Pharmaceutical Industry
  • What constitutes excessive: examining relevance of cost, value indicators and comparators
  • Comparison of approaches and interpretations across different jurisdictions
  • Practical advice on pricing decisions and negotiations in current enforcement landscape

Ingrid Vandenborre, Partner, Antitrust/Competition, Skadden, Arps, Slate, Meagher & Flom LLP

Laetitia Szaller, Associate General Counsel, UCB

Julia Sabine Wahl, Senior Economist, Copenhagen Economics

Wolf Sauter, Expert, The Netherlands Authority for Consumers and Markets (ACM)

Rainer Becker, Head of Unit, DG Competition, European Commission

Merger Control & “Killer Acquisitions”
Merger Control & “Killer Acquisitions”
  • Jurisdictional questions and regime changes: experiences with value-based merger control thresholds
  • Product market definition: what impact will theories of “the molecule as the market” in antitrust cases have for merger control? Is market definition contextual?
  • Novel theories of harm: non-product specific innovation and “killer acquisitions”: what are the implications for the pharma industry?

Alberto Bacchiega, Head of Unit - Merger control, DG Competition, European Commission

Molly Herron, Senior Legal Counsel, Antitrust EMEA, Novartis International AG

James Killick, Partner, White & Case LLP

Latest Trends in Preliminary Injunctions
Latest Trends in Preliminary Injunctions
  • A multi-jurisdictional approach to the latest developments and key trends
  • Review of recent cases and enforcement decisions: the CJEU decision in Bayer v Gedeon Richter and Exeltis (25.9.19)
  • Principles trends and practical tips; for (i) patent amendments (ii) cross-undertakings and (iii) balancing risks

James Horgan, Assistant Managing Counsel, Merck Sharp & Dohme Ltd

Brian Cordery, Joint Head of Patent Litigation, Bristows LLP

Kai Rüting, Partner, Vossius & Partner

Assessing the Current Status of SPCs
Assessing the Current Status of SPCs
  • The latest on SPCs based on 3rd party marketing authorisations: what is the direction of travel?
  • SPCs for novel and inventive formulations: the Abraxis decision: what are the wider implications of this decision?
  • Manufacturing Waiver: implementation, function and impact

Laura Reynolds, Associate General Counsel, European IP and Regulatory Litigation, Teva Pharmaceuticals

Oliver Werner, Head of SPC Working Group, German Patent & Trade Mark Office

Marie Manley, Partner, Head of the UK Life Sciences Practice, Sidley Austin LLP

Competition Law and Patent Litigation 2019 list

Join peers and clients from around the globe at EU Pharmaceutical Law Forum. You will meet the likes of:

  • Alkaloid AD Skopje
  • Allen & Overy Belgium LLP
  • Apollegis
  • Arthur Cox Unlimited Company
  • AstraZeneca spa
  • Baker McKenzie
  • Clifford Chance LLP
  • CMS Hasche Sigle
  • Copenhagen Economics
  • Dabias
  • DLA Piper
  • Freshfields Bruckhaus Deringer LLP
  • Gedeon Richter Plc
  • Gianni Origoni Grippo Cappelli Partners
  • Gomez-Acebo and Pombo Abogados SLP
  • Gun and Partners
  • GW Pharmaceuticals
  • H Lundbeck AS
  • HGF Limited
  • Hikma Pharmaceuticals
  • Hoyng Rokh Monegier LLP
  • Johnson and Johnson

  • K S Partners
  • Leijnse Artz
  • Mannheimer Swartling Advokatbyra AB
  • Merck Sharp & Dohme Limited
  • Mundipharma International
  • NautaDutilh
  • Norgine NV SA
  • Novartis Pharma AG
  • Pinsent Masons LLP
  • Portolano Cavallo
  • Preu Bohlig and Partner
  • Reitstötter Kinzebach
  • RP Law Firm
  • Samsung Bioepis
  • Stibbe
  • Studio Legale Russo Valentini
  • Swedish Orphan Biovitrum AB (publ)
  • Taylor Wessing
  • TESARO Bio GmbH
  • Teva Pharmaceuticals
  • Vondst Advocaten N.V.
  • Westerberg and Partners
  • Zoetis